Merck & Company, Inc.

Halal Rating :
Comfortable
Last Price $77.9
Market Cap $194.98b
1D Change

-0.75 %

1 Year Change

-40.38 %

Next Earnings Date

Yet to be announced

Company Overview

Merck & Co. operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services.

Revenue Sources

Pass

Based on reviewing Merck's product portfolio and revenue streams through their SEC filings and investor relations materials, the company's primary revenue sources come from pharmaceutical products, vaccines, and animal health products. None of these categories constitute haram activities. The company does not derive revenue from alcohol, gambling, pork products, or other prohibited items.

Reliance on Interest

Reporting Date Total Revenue Total Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
March 31, 2025 $15.53b $9.66b - - 0.00% 0.00%
Dec. 31, 2024 $15.62b $11.32b - - 0.00% 0.00%
Sept. 30, 2024 $16.66b $12.73b - - 0.00% 0.00%
June 30, 2024 $16.11b $10.06b - - 0.00% 0.00%

Analysis of Merck's financial statements for the past four quarters shows no material interest income or interest expense relative to their total revenue and expenses. The company's operations are primarily funded through business activities rather than interest-bearing debt or interest-generating investments.

Operational Ethics

Pass

Based on review of public information and SEC filings, Merck maintains operations in various countries but there is no evidence of material ongoing collaboration with entities involved in human rights violations. While the company does business in China, there is no clear evidence of direct collaboration with the Chinese Communist Party. There is also no evidence of current R&D centers or ongoing projects in Israel.

Rating Justification

Member Vote

Agree: 1 Disagree: 5

Login to vote on this

Comments

Recent News & Updates